معرفی
Professor Des Richardson holds the Alan Mackay-Sim Distinguished Chair of Cancer Cell Biology and directs the Centre for Cancer Cell Biology at Griffith University. He is also an NHMRC Senior Principal Research Fellow and leads drug discovery initiatives. His research focuses on developing anti-cancer drugs like Dp44mT and DpC, targeting metastatic and drug-resistant tumors. With over 450 publications and a Google Scholar H-index of 100, his work spans cancer biology, redox mechanisms, and translational medicine.
- Affiliations: Griffith Institute for Drug Discovery, Institute for Biomedicine and Glycomics, Griffith University.
- Research Interests: Anti-cancer therapeutics, metastasis suppression (NDRG1), iron metabolism, and drug resistance mechanisms.
He has secured over $3.5M in NHMRC and industry grants, including projects targeting breast, pancreatic, and neuroblastoma cancers. Notable awards include the SfRBM Mentoring Excellence Award and multiple supervisory recognitions. Richardson has mentored 67 PhD students and supervised 15+ postdocs, many of whom have won prestigious fellowships. His lab collaborates globally, advancing therapies for neurodegenerative diseases and oncology.
